nodes	percent_of_prediction	percent_of_DWPC	metapath
Zanamivir—Lymphopenia—Docetaxel—head and neck cancer	0.0315	0.0315	CcSEcCtD
Zanamivir—Face oedema—Hydroxyurea—head and neck cancer	0.0218	0.0218	CcSEcCtD
Zanamivir—Neutropenia—Hydroxyurea—head and neck cancer	0.0182	0.0182	CcSEcCtD
Zanamivir—Haemoglobin—Vinblastine—head and neck cancer	0.0172	0.0172	CcSEcCtD
Zanamivir—Haemorrhage—Vinblastine—head and neck cancer	0.0171	0.0171	CcSEcCtD
Zanamivir—Haemoglobin—Hydroxyurea—head and neck cancer	0.0157	0.0157	CcSEcCtD
Zanamivir—Influenza like illness—Docetaxel—head and neck cancer	0.0157	0.0157	CcSEcCtD
Zanamivir—Haemorrhage—Hydroxyurea—head and neck cancer	0.0156	0.0156	CcSEcCtD
Zanamivir—Hallucination—Hydroxyurea—head and neck cancer	0.0155	0.0155	CcSEcCtD
Zanamivir—Chills—Hydroxyurea—head and neck cancer	0.014	0.014	CcSEcCtD
Zanamivir—Ill-defined disorder—Vinblastine—head and neck cancer	0.0138	0.0138	CcSEcCtD
Zanamivir—Malaise—Vinblastine—head and neck cancer	0.0134	0.0134	CcSEcCtD
Zanamivir—Convulsion—Vinblastine—head and neck cancer	0.0129	0.0129	CcSEcCtD
Zanamivir—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.0126	0.0126	CcSEcCtD
Zanamivir—Discomfort—Vinblastine—head and neck cancer	0.0125	0.0125	CcSEcCtD
Zanamivir—Malaise—Hydroxyurea—head and neck cancer	0.0122	0.0122	CcSEcCtD
Zanamivir—Convulsion—Hydroxyurea—head and neck cancer	0.0118	0.0118	CcSEcCtD
Zanamivir—Sinusitis—Fluorouracil—head and neck cancer	0.0117	0.0117	CcSEcCtD
Zanamivir—Anorexia—Vinblastine—head and neck cancer	0.0116	0.0116	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.0115	0.0115	CcSEcCtD
Zanamivir—Discomfort—Hydroxyurea—head and neck cancer	0.0114	0.0114	CcSEcCtD
Zanamivir—Haemoglobin—Fluorouracil—head and neck cancer	0.0113	0.0113	CcSEcCtD
Zanamivir—Haemorrhage—Fluorouracil—head and neck cancer	0.0112	0.0112	CcSEcCtD
Zanamivir—Infection—Hydroxyurea—head and neck cancer	0.011	0.011	CcSEcCtD
Zanamivir—Dehydration—Docetaxel—head and neck cancer	0.0109	0.0109	CcSEcCtD
Zanamivir—Skin disorder—Hydroxyurea—head and neck cancer	0.0108	0.0108	CcSEcCtD
Zanamivir—Anorexia—Hydroxyurea—head and neck cancer	0.0106	0.0106	CcSEcCtD
Zanamivir—Decreased appetite—Vinblastine—head and neck cancer	0.0106	0.0106	CcSEcCtD
Zanamivir—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.0105	0.0105	CcSEcCtD
Zanamivir—Pain—Vinblastine—head and neck cancer	0.0104	0.0104	CcSEcCtD
Zanamivir—Arrhythmia—Fluorouracil—head and neck cancer	0.01	0.01	CcSEcCtD
Zanamivir—Feeling abnormal—Vinblastine—head and neck cancer	0.01	0.01	CcSEcCtD
Zanamivir—Bronchospasm—Docetaxel—head and neck cancer	0.00996	0.00996	CcSEcCtD
Zanamivir—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00994	0.00994	CcSEcCtD
Zanamivir—Dyspnoea—Hydroxyurea—head and neck cancer	0.00988	0.00988	CcSEcCtD
Zanamivir—Decreased appetite—Hydroxyurea—head and neck cancer	0.00963	0.00963	CcSEcCtD
Zanamivir—Abdominal pain—Vinblastine—head and neck cancer	0.00961	0.00961	CcSEcCtD
Zanamivir—Fatigue—Hydroxyurea—head and neck cancer	0.00955	0.00955	CcSEcCtD
Zanamivir—Pain—Hydroxyurea—head and neck cancer	0.00948	0.00948	CcSEcCtD
Zanamivir—Neutropenia—Docetaxel—head and neck cancer	0.00947	0.00947	CcSEcCtD
Zanamivir—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00913	0.00913	CcSEcCtD
Zanamivir—Hypersensitivity—Vinblastine—head and neck cancer	0.00895	0.00895	CcSEcCtD
Zanamivir—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.00895	0.00895	CcSEcCtD
Zanamivir—Body temperature increased—Hydroxyurea—head and neck cancer	0.00876	0.00876	CcSEcCtD
Zanamivir—Asthenia—Vinblastine—head and neck cancer	0.00872	0.00872	CcSEcCtD
Zanamivir—Convulsion—Fluorouracil—head and neck cancer	0.00847	0.00847	CcSEcCtD
Zanamivir—Myalgia—Fluorouracil—head and neck cancer	0.00832	0.00832	CcSEcCtD
Zanamivir—Diarrhoea—Vinblastine—head and neck cancer	0.00831	0.00831	CcSEcCtD
Zanamivir—Discomfort—Fluorouracil—head and neck cancer	0.00822	0.00822	CcSEcCtD
Zanamivir—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00816	0.00816	CcSEcCtD
Zanamivir—Haemoglobin—Docetaxel—head and neck cancer	0.00814	0.00814	CcSEcCtD
Zanamivir—Haemorrhage—Docetaxel—head and neck cancer	0.0081	0.0081	CcSEcCtD
Zanamivir—Confusional state—Fluorouracil—head and neck cancer	0.00804	0.00804	CcSEcCtD
Zanamivir—Dizziness—Vinblastine—head and neck cancer	0.00804	0.00804	CcSEcCtD
Zanamivir—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00798	0.00798	CcSEcCtD
Zanamivir—Asthenia—Hydroxyurea—head and neck cancer	0.00795	0.00795	CcSEcCtD
Zanamivir—Infection—Fluorouracil—head and neck cancer	0.00792	0.00792	CcSEcCtD
Zanamivir—Vomiting—Vinblastine—head and neck cancer	0.00773	0.00773	CcSEcCtD
Zanamivir—Erythema multiforme—Docetaxel—head and neck cancer	0.00766	0.00766	CcSEcCtD
Zanamivir—Headache—Vinblastine—head and neck cancer	0.00761	0.00761	CcSEcCtD
Zanamivir—Anorexia—Fluorouracil—head and neck cancer	0.0076	0.0076	CcSEcCtD
Zanamivir—Diarrhoea—Hydroxyurea—head and neck cancer	0.00758	0.00758	CcSEcCtD
Zanamivir—Dizziness—Hydroxyurea—head and neck cancer	0.00733	0.00733	CcSEcCtD
Zanamivir—Chills—Docetaxel—head and neck cancer	0.00727	0.00727	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00727	0.00727	CcSEcCtD
Zanamivir—Arrhythmia—Docetaxel—head and neck cancer	0.00724	0.00724	CcSEcCtD
Zanamivir—Nausea—Vinblastine—head and neck cancer	0.00722	0.00722	CcSEcCtD
Zanamivir—Dyspnoea—Fluorouracil—head and neck cancer	0.00711	0.00711	CcSEcCtD
Zanamivir—Vomiting—Hydroxyurea—head and neck cancer	0.00705	0.00705	CcSEcCtD
Zanamivir—Rash—Hydroxyurea—head and neck cancer	0.00699	0.00699	CcSEcCtD
Zanamivir—Dermatitis—Hydroxyurea—head and neck cancer	0.00698	0.00698	CcSEcCtD
Zanamivir—Headache—Hydroxyurea—head and neck cancer	0.00694	0.00694	CcSEcCtD
Zanamivir—Decreased appetite—Fluorouracil—head and neck cancer	0.00693	0.00693	CcSEcCtD
Zanamivir—Pain—Fluorouracil—head and neck cancer	0.00682	0.00682	CcSEcCtD
Zanamivir—Nausea—Hydroxyurea—head and neck cancer	0.00658	0.00658	CcSEcCtD
Zanamivir—Feeling abnormal—Fluorouracil—head and neck cancer	0.00657	0.00657	CcSEcCtD
Zanamivir—Urticaria—Fluorouracil—head and neck cancer	0.00634	0.00634	CcSEcCtD
Zanamivir—Syncope—Docetaxel—head and neck cancer	0.00633	0.00633	CcSEcCtD
Zanamivir—Body temperature increased—Fluorouracil—head and neck cancer	0.00631	0.00631	CcSEcCtD
Zanamivir—Loss of consciousness—Docetaxel—head and neck cancer	0.0062	0.0062	CcSEcCtD
Zanamivir—Cough—Docetaxel—head and neck cancer	0.00616	0.00616	CcSEcCtD
Zanamivir—Convulsion—Docetaxel—head and neck cancer	0.00611	0.00611	CcSEcCtD
Zanamivir—Myalgia—Docetaxel—head and neck cancer	0.00601	0.00601	CcSEcCtD
Zanamivir—Arthralgia—Docetaxel—head and neck cancer	0.00601	0.00601	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.00596	0.00596	CcSEcCtD
Zanamivir—Hypersensitivity—Fluorouracil—head and neck cancer	0.00588	0.00588	CcSEcCtD
Zanamivir—Confusional state—Docetaxel—head and neck cancer	0.0058	0.0058	CcSEcCtD
Zanamivir—Anaphylactic shock—Docetaxel—head and neck cancer	0.00576	0.00576	CcSEcCtD
Zanamivir—Infection—Docetaxel—head and neck cancer	0.00572	0.00572	CcSEcCtD
Zanamivir—Shock—Docetaxel—head and neck cancer	0.00566	0.00566	CcSEcCtD
Zanamivir—Skin disorder—Docetaxel—head and neck cancer	0.00559	0.00559	CcSEcCtD
Zanamivir—Anorexia—Docetaxel—head and neck cancer	0.00549	0.00549	CcSEcCtD
Zanamivir—Diarrhoea—Fluorouracil—head and neck cancer	0.00546	0.00546	CcSEcCtD
Zanamivir—Dizziness—Fluorouracil—head and neck cancer	0.00527	0.00527	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00525	0.00525	CcSEcCtD
Zanamivir—Dyspnoea—Docetaxel—head and neck cancer	0.00513	0.00513	CcSEcCtD
Zanamivir—Vomiting—Fluorouracil—head and neck cancer	0.00507	0.00507	CcSEcCtD
Zanamivir—Rash—Fluorouracil—head and neck cancer	0.00503	0.00503	CcSEcCtD
Zanamivir—Dermatitis—Fluorouracil—head and neck cancer	0.00502	0.00502	CcSEcCtD
Zanamivir—Decreased appetite—Docetaxel—head and neck cancer	0.005	0.005	CcSEcCtD
Zanamivir—Headache—Fluorouracil—head and neck cancer	0.005	0.005	CcSEcCtD
Zanamivir—Fatigue—Docetaxel—head and neck cancer	0.00496	0.00496	CcSEcCtD
Zanamivir—Pain—Docetaxel—head and neck cancer	0.00492	0.00492	CcSEcCtD
Zanamivir—Feeling abnormal—Docetaxel—head and neck cancer	0.00474	0.00474	CcSEcCtD
Zanamivir—Nausea—Fluorouracil—head and neck cancer	0.00474	0.00474	CcSEcCtD
Zanamivir—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00471	0.00471	CcSEcCtD
Zanamivir—Abdominal pain—Docetaxel—head and neck cancer	0.00455	0.00455	CcSEcCtD
Zanamivir—Body temperature increased—Docetaxel—head and neck cancer	0.00455	0.00455	CcSEcCtD
Zanamivir—Hypersensitivity—Docetaxel—head and neck cancer	0.00424	0.00424	CcSEcCtD
Zanamivir—Asthenia—Docetaxel—head and neck cancer	0.00413	0.00413	CcSEcCtD
Zanamivir—Diarrhoea—Docetaxel—head and neck cancer	0.00394	0.00394	CcSEcCtD
Zanamivir—Dizziness—Docetaxel—head and neck cancer	0.00381	0.00381	CcSEcCtD
Zanamivir—Vomiting—Docetaxel—head and neck cancer	0.00366	0.00366	CcSEcCtD
Zanamivir—Rash—Docetaxel—head and neck cancer	0.00363	0.00363	CcSEcCtD
Zanamivir—Dermatitis—Docetaxel—head and neck cancer	0.00363	0.00363	CcSEcCtD
Zanamivir—Headache—Docetaxel—head and neck cancer	0.00361	0.00361	CcSEcCtD
Zanamivir—Nausea—Docetaxel—head and neck cancer	0.00342	0.00342	CcSEcCtD
